{"transactions":[{"id":4636998,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-10-07T20:11:41.000Z","date":"2026-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":48081,"price":5,"value":240405.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares tendered to the Issuer pursuant to the Issuer's tender offer. The Issuer took up and accepted the common shares for payment on October 1, 2026."}],"balance_after":111882,"source":{"system":"sec-edgar","filing":"0001447028-26-000060","document":"wk-form4_1791403899.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000060/wk-form4_1791403899.xml","form_type":"4"}},{"id":4625866,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":27475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 188,400 shares, vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the February 2, 2026 grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":160925,"derivative":{"exercise_price":4.39,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":27475},"source":{"system":"sec-edgar","filing":"0001447028-26-000052","document":"wk-form4_1790209910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000052/wk-form4_1790209910.xml","form_type":"4"}},{"id":4625865,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-24T00:31:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":false,"shares":265625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 750,000 shares, vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the March 31, 2025 grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":484375,"derivative":{"exercise_price":3.49,"expiration_date":"2035-03-31","underlying":"Common Shares","underlying_shares":265625},"source":{"system":"sec-edgar","filing":"0001447028-26-000052","document":"wk-form4_1790209910.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000052/wk-form4_1790209910.xml","form_type":"4"}},{"id":4625864,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-09-24T00:31:52.000Z","date":"2026-09-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":206637,"price":5.07,"value":1047649.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 206,637 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices."}],"balance_after":159963,"source":{"system":"sec-edgar","filing":"0001447028-26-000052","document":"wk-form4_1790209910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000052/wk-form4_1790209910.xml","form_type":"4"}},{"id":4625863,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-09-24T00:31:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":27475,"price":4.39,"value":120615.25,"ownership":{"direct":true},"balance_after":366600,"source":{"system":"sec-edgar","filing":"0001447028-26-000052","document":"wk-form4_1790209910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000052/wk-form4_1790209910.xml","form_type":"4"}},{"id":4625862,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-09-24T00:31:52.000Z","date":"2026-09-18","kind":"exercise","planned":false,"acquired":true,"shares":265625,"price":3.49,"value":927031.25,"ownership":{"direct":true},"balance_after":339125,"source":{"system":"sec-edgar","filing":"0001447028-26-000052","document":"wk-form4_1790209910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000052/wk-form4_1790209910.xml","form_type":"4"}},{"id":925586,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T20:21:34.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":188400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":188400,"derivative":{"exercise_price":4.39,"expiration_date":"2036-02-02","underlying":"Common Shares","underlying_shares":188400},"source":{"system":"sec-edgar","filing":"0001447028-26-000009","document":"wk-form4_1770081692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000009/wk-form4_1770081692.xml","form_type":"4"}},{"id":925585,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-02-02T20:21:34.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":73500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction."}],"balance_after":73500,"source":{"system":"sec-edgar","filing":"0001447028-26-000009","document":"wk-form4_1770081692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702826000009/wk-form4_1770081692.xml","form_type":"4"}},{"id":1186814,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-01T17:47:47.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":750000,"derivative":{"exercise_price":3.49,"expiration_date":"2035-03-31","underlying":"Common Shares","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001447028-25-000090","document":"wk-form4a_1743544061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702825000090/wk-form4a_1743544061.xml","form_type":"4/A","original_submission_date":"2025-03-31"}},{"id":1188201,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":68246,"kind":"person","name":"Nguyen Tuan","position":1,"cik":"0002063445","reported_name":"Nguyen Tuan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-31T16:24:03.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests over a four-year period, with 25% of the total shares subject to the option vesting on the 1st anniversary of the grant date and the remaining 75% vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":750000,"derivative":{"exercise_price":3.5,"expiration_date":"2035-03-31","underlying":"Common Shares","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001447028-25-000088","document":"wk-form4_1743452635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2063445/000144702825000088/wk-form4_1743452635.xml","form_type":"4"}}]}